CMKLR1 and polycystic ovary syndrome: The protein abundance of CMKLR1 in the uterus was higher in the VD3-treated and PCOS groups (Figure 5F, p  <  0.05) when compared to the controls, while in PCOS rats treated with VD3, we noted lower CMKLR1 expression vs. the control.